search icon
cyth-img

Cyclo Therapeutics Inc, Common Stock

CYTH

NAQ

$0.623

-$0.07

(-10.14%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$20.39M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
36.56K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.38
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.55 L
$2.12 H
$0.623

About Cyclo Therapeutics Inc, Common Stock

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCYTHSectorS&P500
1-Week Return-6.27%0.49%-0.42%
1-Month Return0.65%-3.1%-2.2%
3-Month Return-19.09%-8.59%2.38%
6-Month Return-54.86%-4.57%5.1%
1-Year Return-56.74%-0.94%23.79%
3-Year Return-84.77%2.88%26.66%
5-Year Return-97.51%35.84%81.16%
10-Year Return-98.96%98.8%191.72%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue903.38K1.59M1.38M1.08M1.08M[{"date":"2020-12-31","value":56.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":86.76,"profit":true},{"date":"2023-12-31","value":67.88,"profit":true},{"date":"2024-12-31","value":67.88,"profit":true}]
Cost of Revenue66.40K156.08K138.93K3.49M98.46K[{"date":"2020-12-31","value":1.9,"profit":true},{"date":"2021-12-31","value":4.48,"profit":true},{"date":"2022-12-31","value":3.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":2.82,"profit":true}]
Gross Profit836.98K1.43M1.24M(2.41M)977.95K[{"date":"2020-12-31","value":58.54,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":86.51,"profit":true},{"date":"2023-12-31","value":-168.58,"profit":false},{"date":"2024-12-31","value":68.4,"profit":true}]
Gross Margin92.65%90.16%89.90%(223.91%)90.85%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":97.31,"profit":true},{"date":"2022-12-31","value":97.03,"profit":true},{"date":"2023-12-31","value":-241.67,"profit":false},{"date":"2024-12-31","value":98.06,"profit":true}]
Operating Expenses9.80M15.70M16.85M17.64M21.04M[{"date":"2020-12-31","value":46.57,"profit":true},{"date":"2021-12-31","value":74.63,"profit":true},{"date":"2022-12-31","value":80.1,"profit":true},{"date":"2023-12-31","value":83.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(8.96M)(14.27M)(15.61M)(20.05M)(20.05M)[{"date":"2020-12-31","value":-896013300,"profit":false},{"date":"2021-12-31","value":-1426813300,"profit":false},{"date":"2022-12-31","value":-1561161400,"profit":false},{"date":"2023-12-31","value":-2005005700,"profit":false},{"date":"2024-12-31","value":-2005005700,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(8.94M)(14.29M)(15.45M)(20.06M)(20.06M)[{"date":"2020-12-31","value":-894160300,"profit":false},{"date":"2021-12-31","value":-1428665500,"profit":false},{"date":"2022-12-31","value":-1545088800,"profit":false},{"date":"2023-12-31","value":-2005730200,"profit":false},{"date":"2024-12-31","value":-2005730200,"profit":false}]
Income Taxes(18.53K)18.52K(171.00K)4.00-[{"date":"2020-12-31","value":-100.04,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-923.22,"profit":false},{"date":"2023-12-31","value":0.02,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(8.94M)(14.29M)(15.45M)(19.40M)-[{"date":"2020-12-31","value":-894160300,"profit":false},{"date":"2021-12-31","value":-1428665500,"profit":false},{"date":"2022-12-31","value":-1545088800,"profit":false},{"date":"2023-12-31","value":-1939532000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(8.92M)(14.31M)(15.28M)(20.06M)(20.06M)[{"date":"2020-12-31","value":-892307300,"profit":false},{"date":"2021-12-31","value":-1430517700,"profit":false},{"date":"2022-12-31","value":-1527989000,"profit":false},{"date":"2023-12-31","value":-2005730200,"profit":false},{"date":"2024-12-31","value":-2005730200,"profit":false}]
EPS (Diluted)(2.58)(2.30)(1.83)(1.42)(0.67)[{"date":"2020-12-31","value":-258,"profit":false},{"date":"2021-12-31","value":-230,"profit":false},{"date":"2022-12-31","value":-183,"profit":false},{"date":"2023-12-31","value":-142.47,"profit":false},{"date":"2024-12-31","value":-67,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CYTH
Cash Ratio 0.05
Current Ratio 0.17
Quick Ratio 0.16

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CYTH
ROA (LTM) -282.49%
ROE (LTM) -22663.91%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CYTH
Debt Ratio Lower is generally better. Negative is bad. 3.56
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -2.56

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CYTH
Trailing PE NM
Forward PE NM
P/S (TTM) 18.01
P/B 59.10
Price/FCF NM
EV/R 36.37
EV/Ebitda NM

FAQs

What is Cyclo Therapeutics Inc share price today?

Cyclo Therapeutics Inc (CYTH) share price today is $0.623

Can Indians buy Cyclo Therapeutics Inc shares?

Yes, Indians can buy shares of Cyclo Therapeutics Inc (CYTH) on Vested. To buy Cyclo Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CYTH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cyclo Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Cyclo Therapeutics Inc (CYTH) via the Vested app. You can start investing in Cyclo Therapeutics Inc (CYTH) with a minimum investment of $1.

How to invest in Cyclo Therapeutics Inc shares from India?

You can invest in shares of Cyclo Therapeutics Inc (CYTH) via Vested in three simple steps:

  • Click on Sign Up or Invest in CYTH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cyclo Therapeutics Inc shares
What is Cyclo Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Cyclo Therapeutics Inc (CYTH) is $2.12. The 52-week low price of Cyclo Therapeutics Inc (CYTH) is $0.55.

What is Cyclo Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cyclo Therapeutics Inc (CYTH) is

What is Cyclo Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cyclo Therapeutics Inc (CYTH) is 59.10

What is Cyclo Therapeutics Inc dividend yield?

The dividend yield of Cyclo Therapeutics Inc (CYTH) is 0.00%

What is the Market Cap of Cyclo Therapeutics Inc?

The market capitalization of Cyclo Therapeutics Inc (CYTH) is $20.39M

What is Cyclo Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Cyclo Therapeutics Inc is CYTH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top